OverT Bio: Funding, Investors & Team (Oct 2026)
OverT Bio is a biotech company that offers cell therapy for cancer. The company specializes in creating innovative genetic modifications to help immune cells combat tumor barriers, resulting in more successful and long-lasting immunotherapy treatments for cancer patients. This allows the healthcare sector to better diagnose and treat cancer.
OverT Bio has raised $16.1M across 2 funding rounds on record, the most recent an undisclosed round of $120k announced in Nov 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
OverT Bio Company Profile and Key Stats
Latest funding round on record: Nov 2024.
OverT Bio Funding Rounds
OverT Bio raised $16.0M in a Seed announced in May 2024.
6 months later, an undisclosed round of $120k was announced in Nov 2024.
OverT Bio Founders and Leadership Team
No contact details are on record for this team yet.
OverT Bio Funding Compared to Other Biotechnology Startups
OverT Bio's latest round of $120k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like OverT Bio in Biotechnology and New York
Companies Similar to OverT Bio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
OverT Bio Funding FAQs
What does OverT Bio do?
OverT Bio is a biotech company that offers cell therapy for cancer. The company specializes in creating innovative genetic modifications to help immune cells combat tumor barriers, resulting in more successful and long-lasting immunotherapy treatments for cancer patients. This allows the healthcare sector to better diagnose and treat cancer.
How much funding has OverT Bio raised?
OverT Bio has raised $16.1M across 2 rounds on record. The most recent is an undisclosed round of $120k announced in Nov 2024.
When did OverT Bio last raise funding?
OverT Bio's most recent funding round on record is an undisclosed round of $120k, announced in Nov 2024.
Who founded OverT Bio?
FundedIQ lists Mat Legut (Founder) at OverT Bio.
Where is OverT Bio headquartered?
OverT Bio is based in New York, United States.
How many employees does OverT Bio have?
OverT Bio is in the 1-10 employee band.
How does OverT Bio's funding compare to other Biotechnology startups?
OverT Bio's latest round of $120k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's OverT Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OverT Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.